PATENT CLAIM ANALYSIS

Application Number: 15964771
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to a subtype selective partial agonist of α6 containing nicotinic acetylcholine receptors. Due to its uniquely selective and functional profile, 9-methyl-3-pyridin-3-yl-3,9-diaza-bicyclo[3.3.1]nonane may be useful in the treatment, prevention and/or alleviation of a disease, disorder and/or condition which is responsive to activation of a nicotinic acetylcholine receptor (nAChR) in a subject, wherein the nAChR comprises at least one cholinergic receptor nicotinic alpha 6 subunit (nAChRa6). Preferably, said disease, disorder and/or condition is a Parkinsonian disorder or pain.

Claim (Index 10):
The method according to  claim 9 , wherein the pain is mild pain, moderate pain, severe pain, pain of acute character, pain of chronic character, pain of recurrent character, pain caused by migraine, postoperative pain, phantom limb pain, inflammatory pain, neuropathic pain, chronic headache, central pain, pain related to diabetic neuropathy, pain related to post therapeutic neuralgia, or pain related to peripheral nerve injury.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.49231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12087004', '12160567', '12161905', '12093655', '12593779']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.813872950831928
- 35 USC 102 Novelty (BERT): 0.5430956853215784
- Combined Prediction Score: 0.7867952242808931
- Mean Citation Score: 365.378578
- Max Citation Score: 421.349
- Similarity Product: 231.8677528394461

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test